GlassScriptPhysician profile
Michael S Bobo
NPI 1154612315
$1,075.41
in general payments reported to CMS, 2019-2025
9 companies · $176 in 2025
The $176 reported for 2025 was more than what 80% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.36 · 2020: $85.63 · 2021: $418 · 2022: $262 · 2023: $15.55 · 2024: $66.96 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $305.18 | 2021-2022 | |
| Abbott Laboratories | $250.50 | 2021-2025 | I-Stat |
| Janssen Pharmaceuticals, INC | $184.37 | 2020-2024 | Xarelto |
| Pfizer INC. | $142.49 | 2019-2021 | |
| Inari Medical, INC. | $111.04 | 2021-2022 | |
| Chiesi USA, INC. | $28.85 | 2025 | Cleviprex |
| Z-Medica, LLC | $20.71 | 2020 | |
| Novartis Pharmaceuticals Corporation | $17.16 | 2019 | |
| Purdue Pharma L.P. | $15.11 | 2024 | Nalmefene Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bobo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.